BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 32620611)

  • 1. BNIP3L Is a New Autophagy Related Prognostic Biomarker for Melanoma Patients Treated With AGI-101H.
    Kazimierczak U; Kolenda T; Kowalczyk D; Mackiewicz J; Mackiewicz A
    Anticancer Res; 2020 Jul; 40(7):3723-3732. PubMed ID: 32620611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6.
    Czerwinska P; Rucinski M; Wlodarczyk N; Jaworska A; Grzadzielewska I; Gryska K; Galus L; Mackiewicz J; Mackiewicz A
    Oncoimmunology; 2020; 9(1):1710063. PubMed ID: 32002306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole Cell Therapeutic Vaccine Modified With Hyper-IL6 for Combinational Treatment of Nonresected Advanced Melanoma.
    Mackiewicz J; Karczewska-Dzionk A; Laciak M; Kapcinska M; Wiznerowicz M; Burzykowski T; Zakowska M; Rose-John S; Mackiewicz A
    Medicine (Baltimore); 2015 May; 94(21):e853. PubMed ID: 26020391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective roles of autophagy in retinal pigment epithelium under high glucose condition via regulating PINK1/Parkin pathway and BNIP3L.
    Huang C; Lu H; Xu J; Yu H; Wang X; Zhang X
    Biol Res; 2018 Jul; 51(1):22. PubMed ID: 30012208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of autophagy-related beclin-1 in advanced malignant melanoma and its low expression in melanoma-in-situ.
    Hara Y; Nakamura M
    Eur J Dermatol; 2012; 22(1):128-9. PubMed ID: 22062628
    [No Abstract]   [Full Text] [Related]  

  • 6. Expression and Clinical Significance of BCL2 Interacting Protein 3 Like in Multiple Myeloma.
    Li R; Chen G; Dang Y; He R; Liu A; Ma J; Ling Z
    Technol Cancer Res Treat; 2021; 20():15330338211024551. PubMed ID: 34189969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of
    Wang X; Yu X; Krauthammer M; Hugo W; Duan C; Kanetsky PA; Teer JK; Thompson ZJ; Kalos D; Tsai KY; Smalley KSM; Sondak VK; Chen YA; Conejo-Garcia JR
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1792-1799. PubMed ID: 32611582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.
    Gradilone A; Gazzaniga P; Ribuffo D; Scarpa S; Cigna E; Vasaturo F; Bottoni U; Innocenzi D; Calvieri S; Scuderi N; Frati L; Aglianò AM
    J Clin Oncol; 2003 Jan; 21(2):306-12. PubMed ID: 12525523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
    Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
    PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stage-specific prognostic biomarkers in melanoma.
    Cheng Y; Lu J; Chen G; Ardekani GS; Rotte A; Martinka M; Xu X; McElwee KJ; Zhang G; Zhou Y
    Oncotarget; 2015 Feb; 6(6):4180-9. PubMed ID: 25784655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers.
    Hyams DM; Cook RW; Buzaid AC
    J Surg Oncol; 2019 Jan; 119(2):175-186. PubMed ID: 30548543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of BCL2 19 kD Protein-Interacting Protein 3 (BNIP3) is Predictive of Unfavorable Prognosis in Uveal Melanoma.
    Jiang Z; Yu F; Li M
    Med Sci Monit; 2018 Jul; 24():4711-4717. PubMed ID: 29982263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma.
    Masugi Y; Tanese K; Emoto K; Yamazaki K; Effendi K; Funakoshi T; Mori M; Sakamoto M
    Pathol Int; 2015 Dec; 65(12):627-34. PubMed ID: 26374196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
    Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melastatin expression and prognosis in cutaneous malignant melanoma.
    Duncan LM; Deeds J; Cronin FE; Donovan M; Sober AJ; Kauffman M; McCarthy JJ
    J Clin Oncol; 2001 Jan; 19(2):568-76. PubMed ID: 11208852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of BNIP3 and BNIP3L/Nix expression in cybrid cell lines harboring two LHON-associated mutations.
    Kodroń A; Hajieva P; Kulicka A; Paterczyk B; Jankauskaite E; Bartnik E
    Acta Biochim Pol; 2019 Oct; 66(4):427-435. PubMed ID: 31584786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.
    Shi F; Ding Y; Ju S; Wu X; Cao S
    Biomarkers; 2014 Feb; 19(1):70-6. PubMed ID: 24369732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin mild hypoxia enhances killing of UVB-damaged keratinocytes through reactive oxygen species-mediated apoptosis requiring Noxa and Bim.
    Nys K; Maes H; Andrei G; Snoeck R; Garmyn M; Agostinis P
    Free Radic Biol Med; 2012 Mar; 52(6):1111-20. PubMed ID: 22245094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy.
    Wilfinger N; Austin S; Scheiber-Mojdehkar B; Berger W; Reipert S; Praschberger M; Paur J; Trondl R; Keppler BK; Zielinski CC; Nowikovsky K
    Oncotarget; 2016 Jan; 7(2):1242-61. PubMed ID: 26517689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitophagy mediated by BNIP3 and BNIP3L/NIX in urothelial cells of the urinary bladder of cattle harbouring bovine papillomavirus infection.
    Roperto S; De Falco F; Perillo A; Catoi C; Roperto F
    Vet Microbiol; 2019 Sep; 236():108396. PubMed ID: 31500722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.